Healthcare Providers and Services
Company Overview of City Of Hope
City of Hope, a nonprofit public benefit corporation, operates City of Hope National Medical Center (the Center), City of Hope Medical Foundation, and Beckman Research Institute of the City of Hope. The Center operates a 186-bed tertiary referral center primarily for the treatment of cancer, diabetes, and other life-threatening diseases in Duarte, California. The company was founded in 1913 and is based in Duarte, California.
1500 East Duarte Road
Duarte, CA 91010
Founded in 1913
Key Executives for City Of Hope
Chief Executive Officer and President
Chief Operating Officer and Executive Vice President
Chief Scientific Officer and Provost
Senior Vice President of Research Operations
Compensation as of Fiscal Year 2015.
City Of Hope Key Developments
Tara Immuno-Oncology, LLC Signs Licensing Agreement with City of Hope
Nov 3 15
Tara Immuno-Oncology, LLC has acquired licenses from City of Hope for the development of p53MVA and a Salmonella-based therapy targeting Indoleamine 2,3-Dioxygenase (shIDO-ST). Under the terms of the transaction, Tara will pay City of Hope upfront and payments in excess of $10 million, in addition to commercial royalties for the exclusive licenses.
Glenn D. Steele Jr. Joins City of Hope's Board of Directors
Oct 27 15
Renowned health care leader Glenn D. Steele Jr., M.D., Ph.D., the recent past president and chief executive officer of Geisinger Health System, will join the City of Hope board of directors beginning Jan. 1, 2016. Steele is currently chair of xG Health Solutions.
Victoria L. Seewaldt Joins City of Hope as the Ruth Ziegler Chair in Population Sciences
Sep 29 15
Nationally breast cancer and ovarian cancer specialist Victoria L. Seewaldt, M.D., has joined City of Hope as the Ruth Ziegler Chair in Population Sciences. An expert in cancer prediction and prevention, Seewaldt will advance the institution’s efforts to ensure its research reflects and represents the diversity within City of Hope’s community. A specialist in developing risk models for aggressive cancers, particularly in women of color, Seewaldt will also serve as the associate director of the comprehensive cancer center. Seewaldt comes to City of Hope from Duke University, where she was a professor of medicine and leader of the Comprehensive Cancer Breast and Ovarian Cancer Program. She also founded the institution’s community outreach program for underserved women. Seewaldt will lead the Breast Cancer Early Detection and Health Disparities Program at City of Hope, operating a clinic for women at high risk of breast and ovarian cancers and working to better understand which cancers can be predicted, and thus prevented. She will also work with City of Hope’s community sites to gather information on the areas’ diverse population in order to gain a more thorough understanding of risk and disease progression.
Seewaldt will emphasize clinical trials that focus on keeping high-risk women healthy, as opposed to those that emphasize intervention through medications, which can have serious side effects. She also will work to provide women in the community with health education and improved access to breast cancer screenings and treatment, as well as provide mentorship of young minority scholars.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|